1. Home
  2. KINS vs BDSX Comparison

KINS vs BDSX Comparison

Compare KINS & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KINS

Kingstone Companies Inc.

N/A

Current Price

$22.93

Market Cap

279.5M

Sector

Finance

ML Signal

N/A

Logo Biodesix Inc.

BDSX

Biodesix Inc.

N/A

Current Price

$10.22

Market Cap

276.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KINS
BDSX
Founded
1886
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
279.5M
276.2M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
KINS
BDSX
Price
$22.93
$10.22
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $32.17
AVG Volume (30 Days)
93.7K
★ 237.3K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 1.03%
N/A
EPS Growth
★ 94.59
N/A
EPS
★ 1.86
N/A
Revenue
★ $214,867,301.00
$88,499,000.00
Revenue This Year
$18.83
$18.90
Revenue Next Year
$15.85
$20.34
P/E Ratio
$12.49
★ N/A
Revenue Growth
★ 38.50
24.08
52 Week Low
$13.83
$5.26
52 Week High
$23.42
$31.97

Technical Indicators

Market Signals
Indicator
KINS
BDSX
Relative Strength Index (RSI) 67.82 24.51
Support Level $18.35 $9.43
Resistance Level N/A $16.66
Average True Range (ATR) 0.86 2.15
MACD 0.33 -1.08
Stochastic Oscillator 86.05 14.40

Price Performance

Historical Comparison
KINS
BDSX

About KINS Kingstone Companies Inc.

Kingstone Companies Inc offers property and casualty insurance products through its subsidiary engaged in writing business through retail and wholesale agents and brokers. Its products include Personal lines, Livery physical damage, and Others. It operates in single segment, property and casualty insurance. It derives substantially all of its revenue from KICO, including revenues from earned premiums, ceding commissions from quota share reinsurance, net investment income generated from its investment portfolio, and net realized gains and losses on investment securities.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: